Equity Analyst, LightStream Research

Shifara Samsudeen, FCMA, CGMA

Equity Analyst

Long-Short Analysis on Japan, Asia and the World

LightStream Research

LightStream conducts quantitatively rigorous and data-driven analysis with a focus on Japan and Asia.

We consistently cover the Tech, Consumer and Industrial sectors, and provide ECM and Events coverage more broadly.

We supplement traditional qualitative insights from company relationships with a robust quantitative foundation that examines as much historical data as is available.
We further refine the accuracy of our insights and calls through the use of alternative data to flesh out current trends, and through a valuation framework that emphasises non-superficial peer group selection and a proper attempt to understand the metrics and changes that have driven security valuations in the past.

Equity Bottom-Up

M3 Inc. reported its 2QFY03/21 results last week. Both revenue and operating profit grew significantly compared to the same quarter last year by 28.5% YoY and 65.8% YoY respectively. At the same time, both revenue and OP beat consensus estimates by 7.2% and 26.6% respectively.<figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/170/077/original/image_87776018731604867251678.png?1604867253" class="editor-image img-responsive" data-smartkarma-image-id="170077"></figure><div class="content-caption">Source: Company Disclosures, Cap IQ</div>We discuss the details below.

M3 Inc. reported its 2QFY03/21 results last week. Both revenue and operating profit grew significantly compared to the same quarter last year by 28.5% YoY and 65.8% YoY respectively. At the same time, both revenue and OP beat consensus estimates by 7.2% and 26.6% respectively.Source: Company Disclosures, Cap IQWe discuss the details below.

M3 Inc: Strong Earnings Momentum Continues

Equity Capital Markets

JD Health International, the largest online healthcare platform and retail pharmacy in China has filed for an IPO to list its shares on the Hong Kong Stock Exchange. The company is backed by the Chinese online retail giant JD.Com, and is planning to raise about US$3bn through the IPO.In this insight, we examine the company’s business model and its financials.

JD Health International, the largest online healthcare platform and retail pharmacy in China has filed for an IPO to list its shares on the Hong Kong Stock Exchange. The company is backed by the Chinese online retail giant JD.Com, and is planning to raise about US$3bn through the IPO.In this insight, we examine the company’s business model and its financials.

JD Health Pre-IPO: Poised to Benefit from Structural Changes in Healthcare in China and the Pandemic

<a href="https://www.smartkarma.com/entities/m3-inc" target="_blank" data-smartkarma-citation="entities:13316:1" rel="noopener">M3 Inc (2413 JP)</a>  provides various medical-related services to physicians and healthcare professionals in Japan and overseas. The company operates m3.com, its key platform alongside several other websites and platforms aimed at providing different services such as information provision, marketing services, medical health records and career solutions for physicians and medical practitioners.The company share price has more than doubled to JPY6,380 per share (from JPY2,921 on 26th March 2020) since we last wrote on the company. In this insight, we examine the key catalysts behind the company’s share price rally and the valuation.

M3 Inc (2413 JP)  provides various medical-related services to physicians and healthcare professionals in Japan and overseas. The company operates m3.com, its key platform alongside several other websites and platforms aimed at providing different services such as information provision, marketing services, medical health records and career solutions for physicians and medical practitioners.The company share price has more than doubled to JPY6,380 per share (from JPY2,921 on 26th March 2020) since we last wrote on the company. In this insight, we examine the key catalysts behind the company’s share price rally and the valuation.

M3 Inc: Intelligent Adaption to Covid-19 Should Sustain Medtech Earnings Growth Even Post-Pandemic

Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

Last Week in Event SPACE: Vedanta, Cardinal Res., Japan Retail Fund, HSBC, Opticomm, Tiffany/LVMH

Index Rebal/Special Situations, Quiddity Advisors

Janaghan Jeyakumar, CFA

Index Rebal/Special Situations

TSE Mothers-listed <a href="https://www.smartkarma.com/entities/medpeer-inc" target="_blank" data-smartkarma-citation="entities:4090:1" rel="noopener">Medpeer Inc (6095 JP)</a> announced (<a href="https://ssl4.eir-parts.net/doc/6095/tdnet/1881489/00.pdf" target="_blank" rel="noopener">J-only</a>) after market close today it had received approval to move to TSE1 as of 15th September 2020. TSE1 reassignment triggers inclusion into the TOPIX Index and the Inclusion Event can be expected to be at the close of trading 29th October 2020. MedPeer is a health-tech company that mainly operates a "doctors-only" social-media platform that enables online knowledge sharing between doctors. This "collective medical intelligence" is then used to provide marketing solutions for pharmaceutical companies and medical device manufacturers. They also provide virtual healthcare solutions to online medical consultation and dietary coaching services. In this insight, we take a look at the Index Inclusion Parameters and the Fundamentals of the company to evaluate the upside potential of the TOPIX Inclusion Event and the trade on the follow.

TSE Mothers-listed Medpeer Inc (6095 JP) announced (J-only) after market close today it had received approval to move to TSE1 as of 15th September 2020. TSE1 reassignment triggers inclusion into the TOPIX Index and the Inclusion Event can be expected to be at the close of trading 29th October 2020. MedPeer is a health-tech company that mainly operates a "doctors-only" social-media platform that enables online knowledge sharing between doctors. This "collective medical intelligence" is then used to provide marketing solutions for pharmaceutical companies and medical device manufacturers. They also provide virtual healthcare solutions to online medical consultation and dietary coaching services. In this insight, we take a look at the Index Inclusion Parameters and the Fundamentals of the company to evaluate the upside potential of the TOPIX Inclusion Event and the trade on the follow.

Japan

M3, Inc. supplies medical information services for doctors through the Internet. The Company also supports marketing of pharmaceutical companies and medical equipment manufacturers.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

M3 Inc (2413 JP)

M3 Inc: Strong Earnings Momentum Continues

M3 reported its 2QFY03/21 results which saw both revenue and operating profit grew significantly compared to the same quarter last year by 28.5%...

Shifara Samsudeen, FCMA, CGMA

JD Health Pre-IPO: Poised to Benefit from Structural Changes in Healthcare in China and the Pandemic

JD Health, the largest online retail pharmacy and healthcare platform has filed for an IPO on the HKEX to raise about US$3bn. In this insight, we...

Shifara Samsudeen, FCMA, CGMA

M3 Inc: Intelligent Adaption to Covid-19 Should Sustain Medtech Earnings Growth Even Post-Pandemic

M3 Inc (2413 JP) provides various medical-related services to physicians and healthcare professionals in Japan and overseas. The company operates...

Shifara Samsudeen, FCMA, CGMA

Last Week in Event SPACE: Vedanta, Cardinal Res., Japan Retail Fund, HSBC, Opticomm, Tiffany/LVMH

Last Week in Event SPACE ... Plus, other events, CCASS movements and Mood Spins. (This insight covers specific insights & comments...

David Blennerhassett

TOPIX Inclusion (6095 JP): MedPeer Inc

Medpeer Inc (6095 JP)

Janaghan Jeyakumar, CFA

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)